Drug Delivery
INT’s Multi-Cargo Lipid Nanoparticle can co-load different drug modalities into the same nanoparticle to ensure optimal pharmacokinetics and bio-distribution in combination therapies.
INT Multi-Cargo Lipid Nanoparticle
Lipid nanoparticles (LNPs) are carefully designed drug delivery technologies that can target drugs to their sites of action, and release drugs in a controlled manner.
Despite progress in drug discovery, many compounds have undesirable physiochemical or pharmacokinetic properties, or are unable to reach their intracellular destination due to their inability to cross cell membranes.
INT’s patented ScaffoLD® lipid technology reliably encapsulates diverse drug modalities—small molecules, RNA/DNA, and peptides—within our LNP delivery system.
The LNP is precisely engineered to accumulate at sites of inflammation or cancer, efficiently enter disease cells, and release its payload inside the cell.
The result is drugs that are safer and more effective.
✓ Multiple antigens for mRNA
✓ Co-delivery of small molecules
✓ Plug-and-play design
✓ Scalable and adaptable
✓ Repeatable across diseases
INT’s Technology can be Applied to Multiple Indications
